The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine.

The Korean journal of internal medicine(2023)

引用 0|浏览29
暂无评分
摘要
This study suggested that combining ΔVAF ≥ 58.6%, a molecular response, with morphologic and hematologic responses can more accurately predict OS in elderly AML patients after decitabine therapy.
更多
查看译文
关键词
Acute myeloid leukemia, Elderly patients, Decitabine, Allele frequency, Residual neoplasm
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要